Apart from these typical chondrogenic markers, we also investigated the expression of the typical “rejection” proteins, major histocompatibility complex (MHC) class I and II, as well as of p63, a member of the p53 tumor suppressor gene family. This evidence concerns the gene TP53 and neoplasm.